Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

4
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
4
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

3
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
3
Neural Regulation01:37

Neural Regulation

45.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

1
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
1
Amyloid Fibrils03:03

Amyloid Fibrils

13.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases.

NPJ Parkinson's disease·2026
Same author

Progress in modelling ATP13A2-linked neurodegeneration.

NPJ Parkinson's disease·2026
Same author

Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma.

Nature communications·2025
Same author

Alzheimer's Tau seeds-induced pathology enhances hippocampal extracellular diffusion.

Communications biology·2025
Same author

Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson's disease.

NPJ Parkinson's disease·2025
Same author

Gliogenesis from the subventricular zone modulates the extracellular matrix at the glial scar after brain ischemia.

eLife·2025

Related Experiment Video

Updated: Apr 18, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.5K

Alpha-synuclein spreading in Parkinson's disease.

Ariadna Recasens1, Benjamin Dehay2

  • 1Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute - Center for Networked Biomedical Research on Neurodegenerative Diseases Barcelona, Spain.

Frontiers in Neuroanatomy
|January 8, 2015
PubMed
Summary

Misfolded alpha-synuclein (α-syn) protein aggregates in Parkinson's disease (PD) may spread like prions. This "prion-like hypothesis" suggests α-syn propagation contributes to PD progression and pathogenesis.

Keywords:
Parkinson diseaseaggregationneurodegenerative diseasesspreadingα-synuclein

More Related Videos

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.3K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.5K
Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.3K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.8K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Misfolded protein aggregates characterize neurodegenerative diseases.
  • Alpha-synuclein (α-syn) aggregation is central to Parkinson's disease (PD) pathogenesis.
  • The "host to graft transmission" or "prion-like hypothesis" proposes α-syn self-propagation.

Purpose of the Study:

  • To review and discuss current knowledge on the prion-like nature of α-syn.
  • To examine the evidence for α-syn self-propagation in PD.
  • To clarify the appropriate use of the term "prion-like" in this context.

Main Methods:

  • Review of in vitro and in vivo studies on α-syn aggregation and propagation.
  • Analysis of histopathological findings, including Lewy bodies (LB) in grafted neurons.
  • Discussion of experimental evidence supporting cell-to-cell and region-to-region spread of α-syn.

Main Results:

  • Evidence suggests α-syn can undergo templated conformational changes.
  • α-syn appears capable of spreading from cell to cell and brain region to region.
  • Formation of "LB-like aggregates" is observed, supporting the prion-like hypothesis.

Conclusions:

  • The prion-like hypothesis provides a framework for understanding α-syn propagation in PD.
  • α-syn's ability to self-propagate is a key factor in PD pathogenesis.
  • Further research is needed to fully elucidate the mechanisms and implications of α-syn prion-like behavior.